PDE1-IN-3

• UNSPSC Description:

  PDE1-IN-3, compound 4 (WO2019156861), is a selective human phosphodiesterase 1 (PDE1) inhibitor. PDE1-IN-3 inhibits PDE4D and PDE6AB with IC50 values of 23.99 μM and 10 μM, respectively[1].

• Target Antigen:

  Phosphodiesterase (PDE)

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/pde1-in-3.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C1C2=NN=C(C3(C4CC4)CC3)N2C(C)=C(C)N1CC5CCC5

• Molecular Weight:

  312.41

• References & Citations:

  [1]Nicholas Paul Camp, et al. [1,2,4]triazolo[4,3-a]pyrazin-8-one derivatives

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2370966-46-2